4-butyrolactone has been researched along with cysteine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ethiraj, KS; Hakimelahi, GH; Hakimelahi, S; Moosavi-Movahedi, AA; Pasdar, M; Sambaiah, T; Zhu, JL | 1 |
| Aćimović, JM; Jovanović, VB; Mandić, LM; Pavićević, ID; Ristić-Medić, DK; Takić, MM; Uzelac, TN | 1 |
2 other study(ies) available for 4-butyrolactone and cysteine
| Article | Year |
|---|---|
Reactions of purines-containing butenolides with L-cysteine or N-acetyl-L-cysteine as model biological nucleophiles: a potent mechanism-based inhibitor of ribonucleotide reductase caused apoptosis in breast carcinoma MCF7 cells.
Topics: 4-Butyrolactone; Acetylcysteine; Animals; Antineoplastic Agents; Apoptosis; Cell Division; Cell Line; Cysteine; Cytarabine; Dose-Response Relationship, Drug; Escherichia coli; Fibroblasts; Furans; Humans; Mice; Molecular Structure; Purines; Ribonucleotide Reductases; Sulfhydryl Compounds; Tumor Cells, Cultured | 2002 |
Binding of enterolactone and enterodiol to human serum albumin: increase of cysteine-34 thiol group reactivity.
Topics: 4-Butyrolactone; Antioxidants; Binding Sites; Cysteine; Humans; Lignans; Protein Binding; Serum Albumin; Spectrometry, Fluorescence; Sulfhydryl Compounds | 2016 |